Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer’s disease pathology

Medicine and Dentistry

• Alzheimer's Disease 100%
• Treatment of Alzheimer's Disease 100%
• Glucagon Like Peptide 1 100%
• Insulin Resistance 60%
• Cognitive Defect 40%
• Serositis 20%
• Clinical Study 20%
• Type 2 Diabetes 20%
• Antiinflammatory Activity 20%
• Neurogenesis 20%
• Antidiabetic Agent 20%
• Cell Signaling Pathway 20%
• Disease Exacerbation 20%
• Amyloid Plaque 20%
• Synaptogenesis 20%
• Pathology of Alzheimer's Disease 20%
• Insulin Signaling 20%
• Cell Regeneration 20%
• Neuroprotective Agent 20%

Neuroscience

• Treatment of Alzheimer's Disease 100%
• Glucagon-Like Peptide-1 100%
• Alzheimer's Disease 100%
• Cognitive Disorders 33%
• Cell Signaling 16%
• Anti-Inflammatory 16%
• Neuroprotective Agent 16%
• Synaptogenesis 16%
• Insulin Signaling 16%
• Cell Regeneration 16%
• Amyloid Protein 16%
• Neurogenesis 16%
• Plaque 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Glucagon-Like Peptide-1 100%
• Alzheimer's Disease 100%
• Insulin Resistance 42%
• Cognitive Defect 28%
• Clinical Study 14%
• Mimetic Drug 14%
• Antiinflammatory Activity 14%
• Repurposing 14%
• Disease Exacerbation 14%
• Amyloid Plaque 14%
• Antidiabetic Agent 14%
• Inflammation 14%
• Neuroprotective Agent 14%